As of Aug 30
| 0.00 / 0.00%|
The 6 analysts offering 12-month price forecasts for Infinity Pharmaceuticals Inc have a median target of 2.00, with a high estimate of 17.00 and a low estimate of 1.00. The median estimate represents a +25.00% increase from the last price of 1.60.
The current consensus among 8 polled investment analysts is to Hold stock in Infinity Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.